Literature DB >> 21080277

Inducible transgenic mouse models.

Thomas L Saunders1.   

Abstract

Inducible transgenic mouse models allow for the activation of genes in specific cells and tissues at specific times. Expression levels are dependent on the dose of the agent administered. Effective experimental models are characterized by low background levels of the regulated gene and induction to high levels with sub-physiological levels of inducing agents. The most commonly used methods to control gene expression in mouse models are based on the tet-operon/repressor bi-transgenic system and the estrogen receptor (ER) ligand-binding domain. Less commonly used systems to control gene expression in transgenic mice take advantage of the ligand-binding domain of the progesterone receptor, and the lac and GAL4 inducible systems. The tetracycline-regulated transgenic models are typically designed to activate the expression of the gene of interest in a specific cell type at a specific point in time. The ER is most commonly fused with Cre recombinase, although it can be used with transcription factors, kinases, etc., that are active in the nucleus. Cre-ER transgenes allow for the induction of recombinase activity in specific cells at defined time points. Cre recombinase is most often found in combination with conditional alleles to inactivate gene expression. When used for gene activation, Cre removes stop cassettes from transgenes and thus allows the expression of reporter or other molecules. Thus, the tetracycline-regulated and Cre-ER systems are complementary in mouse models, with utility in the cell-specific activation and inactivation of gene expression.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21080277     DOI: 10.1007/978-1-60761-974-1_7

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  21 in total

Review 1.  Animal models of skin disease for drug discovery.

Authors:  Pinar Avci; Magesh Sadasivam; Asheesh Gupta; Wanessa Cma De Melo; Ying-Ying Huang; Rui Yin; Rakkiyappan Chandran; Raj Kumar; Ayodeji Otufowora; Theodore Nyame; Michael R Hamblin
Journal:  Expert Opin Drug Discov       Date:  2013-01-08       Impact factor: 6.098

2.  Preclinical models for interrogating drug action in human cancers using Stable Isotope Resolved Metabolomics (SIRM).

Authors:  Andrew N Lane; Richard M Higashi; Teresa W-M Fan
Journal:  Metabolomics       Date:  2016-06-29       Impact factor: 4.290

3.  Know Your Model: Recombinase-expressing mice.

Authors:  Michelle N Perry; Susan M Bello; Cynthia L Smith
Journal:  Lab Anim (NY)       Date:  2020-07       Impact factor: 12.625

Review 4.  New insights into mechanisms of stem cell daughter fate determination in regenerative tissues.

Authors:  Aiko Sada; Tudorita Tumbar
Journal:  Int Rev Cell Mol Biol       Date:  2013       Impact factor: 6.813

5.  Mouse model of enlarged vestibular aqueducts defines temporal requirement of Slc26a4 expression for hearing acquisition.

Authors:  Byung Yoon Choi; Hyoung-Mi Kim; Taku Ito; Kyu-Yup Lee; Xiangming Li; Kelly Monahan; Yaqing Wen; Elizabeth Wilson; Kiyoto Kurima; Thomas L Saunders; Ronald S Petralia; Philine Wangemann; Thomas B Friedman; Andrew J Griffith
Journal:  J Clin Invest       Date:  2011-10-03       Impact factor: 14.808

Review 6.  Genetically manipulated mouse models of lung disease: potential and pitfalls.

Authors:  Rebecca M Baron; Alexander J S Choi; Caroline A Owen; Augustine M K Choi
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-12-23       Impact factor: 5.464

7.  Stability of Doxycycline in Feed and Water and Minimal Effective Doses in Tetracycline-Inducible Systems.

Authors:  Irka M Redelsperger; Tony Taldone; Elyn R Riedel; Michelle L Lepherd; Neil S Lipman; Felix R Wolf
Journal:  J Am Assoc Lab Anim Sci       Date:  2016       Impact factor: 1.232

Review 8.  Genetically engineered mice as experimental tools to dissect the critical events in breast cancer.

Authors:  Mitchell E Menezes; Swadesh K Das; Luni Emdad; Jolene J Windle; Xiang-Yang Wang; Devanand Sarkar; Paul B Fisher
Journal:  Adv Cancer Res       Date:  2014       Impact factor: 6.242

9.  An efficient inducible RPE-Selective cre transgenic mouse line.

Authors:  Ming Chen; Lily Kim; Carolyn W Lu; Hong Zeng; Douglas Vollrath
Journal:  Exp Eye Res       Date:  2020-11-29       Impact factor: 3.467

10.  Modeling Murine Gastric Metaplasia Through Tamoxifen-Induced Acute Parietal Cell Loss.

Authors:  Jose B Saenz; Joseph Burclaff; Jason C Mills
Journal:  Methods Mol Biol       Date:  2016
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.